Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Income Statement [Abstract]
Revenue	$ 1,926,660	$ 606,619	$ 3,793,395	$ 2,317,034
Cost of revenue	855,338	329,227	1,592,851	996,121
Gross margin	1,071,322	277,392	2,200,544	1,320,913
Operating expenses:
Research and development	345,666	433,065	1,250,430	1,306,986
Selling, general and administrative	3,270,757	2,669,375	9,766,189	8,228,114
Total operating expenses	3,616,423	3,102,440	11,016,619	9,535,100
Loss from operations	(2,545,101)	(2,825,048)	(8,816,075)	(8,214,187)
Other expense (income)
Change in fair value of derivative liabilities	(888)	(14,536)	(122,706)	(155,955)
Interest income and other expense, net	29,915	(22,394)	254,039	(106,727)
Non-cash interest expense, debt discount	12,135		218,803
Loss on extinguishment of debt	189,155		696,436
Total other expense (income)	230,317	(36,930)	1,046,572	(262,682)
Loss before income taxes	(2,775,418)	(2,788,118)	(9,862,647)	(7,951,505)
Income tax expense	1,153		2,851
Net loss	(2,776,571)	(2,788,118)	(9,865,498)	(7,951,505)
Deemed dividend on repricing of warrants			(670,632)	(797,637)
Net loss attributable to common stockholders	$ (2,776,571)	$ (2,788,118)	$ (10,536,130)	$ (8,749,142)
Weighted average number of common shares outstanding:
Basic and diluted	3,940,113	571,957	2,901,398	547,091
Net loss per share attributable to common stockholders
Basic and diluted	$ (0.70)	$ (4.87)	$ (3.63)	$ (15.99)